ETV7 and neoplasm: Accumulating experimental evidence indicates that ETV7 also plays a significant role in the mTOR signaling pathway by assembling the mTOR3 complex, which can stimulate cell proliferation and is not sensitive to rapamycin, a common anti-tumor agent, unlike mTOR1/2 (Harwood et al., 2018).